Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.

Kim S, Steelman AJ, Zhang Y, Kinney HC, Li J.

Brain Pathol. 2012 Jan;22(1):41-57. doi: 10.1111/j.1750-3639.2011.00501.x. Epub 2011 Aug 16.

2.

Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.

Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D.

Glia. 2007 Jan 1;55(1):57-64.

PMID:
17009237
3.

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.

van Doorn R, Nijland PG, Dekker N, Witte ME, Lopes-Pinheiro MA, van het Hof B, Kooij G, Reijerkerk A, Dijkstra C, van van der Valk P, van Horssen J, de Vries HE.

Acta Neuropathol. 2012 Sep;124(3):397-410. doi: 10.1007/s00401-012-1014-4. Epub 2012 Jul 19.

PMID:
22810490
4.

Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.

Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, Ffrench-Constant C, Franklin RJ, Hoekstra D, Zhao C, Baron W.

Brain. 2013 Jan;136(Pt 1):116-31. doi: 10.1093/brain/aws313.

5.

Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.

Loda E, Balabanov R.

Rev Neurosci. 2012 Jan 26;23(2):145-52. doi: 10.1515/revneuro-2011-068. Review.

PMID:
22499673
6.

BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions.

Kipp M, Gingele S, Pott F, Clarner T, van der Valk P, Denecke B, Gan L, Siffrin V, Zipp F, Dreher W, Baumgartner W, Pfeifenbring S, Godbout R, Amor S, Beyer C.

Brain Behav Immun. 2011 Nov;25(8):1554-68. doi: 10.1016/j.bbi.2011.05.003. Epub 2011 May 17.

PMID:
21620951
7.

Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C.

J Exp Med. 2006 Feb 20;203(2):425-35. Epub 2006 Feb 13.

8.

Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.

Rodriguez EG, Wegner C, Kreutzfeldt M, Neid K, Thal DR, Jürgens T, Brück W, Stadelmann C, Merkler D.

Acta Neuropathol. 2014 Aug;128(2):231-46. doi: 10.1007/s00401-014-1260-8. Epub 2014 Feb 25.

9.

Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia.

Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC.

J Neuropathol Exp Neurol. 2003 May;62(5):441-50.

10.

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.

Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J.

J Neurocytol. 2002 Jul-Aug;31(6-7):523-36.

PMID:
14501221
11.

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE.

J Neurosci. 2004 May 5;24(18):4412-20.

12.

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.

Vergo S, Craner MJ, Etzensperger R, Attfield K, Friese MA, Newcombe J, Esiri M, Fugger L.

Brain. 2011 Feb;134(Pt 2):571-84. doi: 10.1093/brain/awq337. Epub 2011 Jan 13.

13.

Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.

Herrero-Herranz E, Pardo LA, Bunt G, Gold R, Stühmer W, Linker RA.

Am J Pathol. 2007 Aug;171(2):589-98. Epub 2007 Jun 28.

14.

Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.

Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.

Glia. 2006 May;53(7):696-703.

PMID:
16498619
15.

SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.

Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Nait Oumesmar B.

Glia. 2013 Oct;61(10):1659-72. doi: 10.1002/glia.22547. Epub 2013 Aug 5.

PMID:
23918253
16.

Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.

Plant SR, Wang Y, Vasseur S, Thrash JC, McMahon EJ, Bergstralh DT, Arnett HA, Miller SD, Carson MJ, Iovanna JL, Ting JP.

Glia. 2006 Apr 1;53(5):529-37.

17.

CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.

Omari KM, John GR, Sealfon SC, Raine CS.

Brain. 2005 May;128(Pt 5):1003-15. Epub 2005 Mar 17.

18.

Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis.

Qin J, Berdyshev E, Goya J, Natarajan V, Dawson G.

J Biol Chem. 2010 May 7;285(19):14134-43. doi: 10.1074/jbc.M109.076810. Epub 2010 Mar 9.

19.

Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.

Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa KA.

Glia. 2012 Jul;60(7):1053-66. doi: 10.1002/glia.22334. Epub 2012 Mar 27.

PMID:
22461072
20.

Expression of the low-affinity neurotrophin receptor, p75(NTR), is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination.

Petratos S, Gonzales MF, Azari MF, Marriott M, Minichiello RA, Shipham KA, Profyris C, Nicolaou A, Boyle K, Cheema SS, Kilpatrick TJ.

Glia. 2004 Oct;48(1):64-75.

PMID:
15326616
Items per page

Supplemental Content

Write to the Help Desk